|1.||Wood, Paul L: 5 articles (08/2015 - 01/2010)|
|2.||Maeba, Ryouta: 5 articles (05/2014 - 02/2007)|
|3.||Ford, David A: 5 articles (07/2008 - 02/2002)|
|4.||Okazaki, Tomoki: 4 articles (05/2014 - 02/2007)|
|5.||Hartmann, Tobias: 4 articles (01/2012 - 11/2007)|
|6.||Grimm, Marcus O W: 4 articles (01/2012 - 11/2007)|
|7.||Albert, Carolyn J: 4 articles (07/2008 - 02/2002)|
|8.||Brites, Pedro: 3 articles (01/2015 - 02/2009)|
|9.||Acar, Niyazi: 3 articles (12/2014 - 12/2009)|
|10.||Bretillon, Lionel: 3 articles (12/2014 - 12/2009)|
|1.||Gaucher Disease (Gaucher's Disease)
05/01/2014 - "Serum plasmalogens (Pls) (1-O-alk-1'-enyl-2-acyl glycerophospholipids) are of particular interest for studies on metabolic disorders associated with oxidative stress and chronic inflammation. "
02/08/2002 - "Taken together, these studies demonstrate for the first time a novel biochemical mechanism that targets the vinyl ether bond of plasmalogens during neutrophil activation resulting in the production of alpha-chloro fatty aldehydes that may enhance the recruitment of neutrophils to areas of active inflammation."
02/01/2014 - "Specific biomarkers of its formation during inflammation include 3-chlorotyrosine, chlorinated products of plasmalogens, and glutathione sulfonamide. "
06/19/1995 - "This finding is discussed with respect to atherogenesis and the recently postulated protective qualities of plasmalogens."
01/01/2012 - "Serum plasmalogens (Pls) have gained interest in several clinical symptoms such as metabolic syndrome/atherosclerosis or Alzheimer's disease possibly because of their antioxidant properties. "
11/01/1966 - "[A study of plasmalogens and other lipids in the blood serum in experimental atherosclerosis]."
01/01/2014 - "An increase in serum plasmalogens (1-O-alk-1-enyl-2-acyl glycerophospholipids), which are endogenous anti-oxidative phospholipids, can potentially prevent age-related diseases such as atherosclerosis and metabolic syndrome (MetS). "
01/01/2007 - "Thirty years ago, Kurt Oster promulgated the avant-garde theory that bovine xanthine oxidase, absorbed intact from homogenized milk, promoted atherogenesis by oxidatively damaging membrane plasmalogens. "
|4.||Atherosclerotic Plaque (Atheroma)
12/23/2003 - "The present studies demonstrate that plasmalogens are attacked by MPO-derived reactive chlorinating species within human atheroma. "
07/01/2008 - "2-Chlorohexadecanal (2-ClHDA), a 16-carbon chain chlorinated fatty aldehyde that is produced by reactive chlorinating species attack of plasmalogens, is elevated in atherosclerotic plaques, infarcted myocardium, and activated leukocytes. "
06/23/2006 - "MPO-derived reactive chlorinating species attack membrane plasmalogens releasing alpha-chloro fatty aldehydes including 2-chlorohexadecanal (2-ClHDA), which have been found to accumulate in activated neutrophils, activated monocytes, infarcted myocardium and human atheromas. "
|5.||Schizophrenia (Dementia Praecox)
02/01/2015 - "Our results suggest that alterations in lipid transport or lipid remodeling/metabolism of plasmalogens are present in schizophrenia and that changes in the steady-state levels of these complex lipid pools may be involved in altered neuronal function."
08/15/2012 - "Impaired plasmalogens in patients with schizophrenia."
08/01/2015 - "Our previous lipidomics studies demonstrated elevated sulfatides, plasmalogens, and N-acylphosphatidylserines in the frontal cortex of schizophrenia subjects. "
08/01/2015 - "We undertook a targeted lipidomics analysis of plasmalogens, sulfatides, and N-acyl-phosphatidylserines in the frontal cortex obtained from schizophrenia, bipolar, and ALS subjects and the cerebellum of schizophrenia subjects. "
08/01/2015 - "We demonstrate that sulfatides, plasmalogens, and N-acyl-phosphatidylserines are significantly elevated in the frontal cortex of patients suffering from schizophrenia and bipolar depression but not in ALS patients. "
|3.||vinyl ether (divinyl ether)
|7.||Fatty Acids (Saturated Fatty Acids)
|9.||Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
|2.||Renal Replacement Therapy (Therapies, Renal Replacement)